|
|
| Author |
Message |
The Ferryman science forum beginner
Joined: 23 Jun 2006
Posts: 3
|
Posted: Tue Jun 27, 2006 2:17 pm Post subject:
eCheminfo Drug Discovery Community of Practice Meeting, Bryn Mawr, Philadelphia, 16-19 Oct 06 - Preliminary Program, Early Registration
|
|
|
The eCheminfo Community of Practice InterAction Meeting "Latest
Advances in Drug Discovery Design & Planning Methods" will take place
16-19 October 2006, Bryn Mawr, Philadelphia, USA
Program themes include Structure-based Drug Design, Screening &
Docking, Cheminformatics & Modeling supporting Medicinal Chemistry,
Pharmacophores, Metabolomics, Quantum Biochemistry, Knowledge
Management, Electronic Lab Notebooks, Critical Path Innovation in Drug
Development, Biomarkers, Predictive Toxicology & ADME. In addition to
morning presentations and panel discussions, workshops will run each
afternoon expanding on the discussion of topics and methods and working
through the application of new methods and software to drug discovery &
development problems, with bbq, social activity and poster sessions
running on campus during the evenings.
The preliminary program and schedule is available at:
http://www.echeminfo.com/COMTY_conferences/
Reduced rates apply for early registration through 30 June. Academic
discounts apply.
All registrants are eligible to submit an abstract (ca. 300 words) for
the poster sessions.
Please address any questions related to the conference, exhibition or
workshop program to barry.hardy [at] douglasconnect.com. Registration
enquiries should be directed to eCheminfo [at] douglasconnect.com
best regards
Barry Hardy
eCheminfo Community of Practice
Douglas Connect
Baermeggenweg 14, Zeiningen
CH-4314, Switzerland
Tel: +41 61 851 0170
Confirmed Speakers at the Bryn Mawr meeting include:
Frank Hollinger (Locus Pharmaceuticals), Erin Duffy (Rib-X), Mike
Malams (Wyeth), Debananda Das (NCI), Max Cummings (Johnson & Johnson
PR&D), Lance Westerhoff (QuantumBio), Jose Duca (Schering-Plough),
Osman Guner (Turquoise Consulting), Hege Beard (Schrodinger), Stan
Young (NISS), John Irwin (UCSF), William Douglas Figg (NCI), Daryll
Reid (Simbiosys), Gregory Warren (GlaxoSmithKline), Deepak
Bandyopadhyay (Johnson & Johnson PR&D), Paul Hawkins (OpenEye), Chris
Cooper (BMS), James Arnold (Astra-Zeneca), Phil Edwards (Astra-Zeneca),
Pete Connolly (Johnson & Johnson PR&D), Dimitris Agrafiotis (Johnson &
Johnson PRD), Jim Wikel (Coalesix), Tudor Oprea (Univ. New Mexico),
Alex Tropsha (UNC), Curt Breneman (RPI), Sanji Bhal (ACD/Labs), Michael
Bolger (Simulations Plus), Bob Clark (Tripos), Gilles Klopman
(Multicase), Navita Mallalieu (Roche Pharmaceuticals), Deepak
Bandyopadhyay (Johnson & Johnson PR&D), Zentam Tsuchihashi (BMS), Peter
Henstock (Pfizer), Darius Dziuda (Multivariate bioMarkers Discovery),
Keith Elliston (Genstruct), Michael Liebman (Windber Research
Institute), Jonathan Sheldon (InforSense), Duane Shugars (Concentia
Digital), Jian Wang (Biofortis), Peter Gates (Johnson & Johnson PR&D),
Barry Hardy (Douglas Connect), Dennis Underwood (Praxeon), Jeff
Spitzner (Rescentris), David Mosenkis (Spotfire), Joel Hoffman
(IntraSphere), Delia Wolf (Harvard Medical School), Craig Liddell
(Realtime Science), Joseph Bitran (Enterprizer), Alvin Berger
(Metabolon), Gregory Banik (Bio-RAD), George Harrigan (Monsanto), Rick
Beger (NCTR, FDA), Don Robertson (Pfizer), Teresa Garret (Duke
University), Laszlo Boros (SIDMAP), Bruce Kristal (Cornell University),
Andrew Lane (JG Brown Cancer Center, U. Louisville), Oliver Fiehn (UC
Davis Genome Center), Susan Connor (Glaxo SmithKline) |
|
| Back to top |
|
 |
The Ferryman science forum beginner
Joined: 23 Jun 2006
Posts: 3
|
Posted: Thu Jul 13, 2006 2:33 pm Post subject:
Re: Poster Session/ eCheminfo Drug Discovery Community of Practice Meeting, Bryn Mawr, Philadelphia, 16-19 Oct 06 - Preliminary Program, Early Registration
|
|
|
We will hold a "traditional" poster session at the Autumn eCheminfo
Meeting "Latest Advances in Drug Discovery Design & Planning Methods"
which takes place 16-19 October 2006, Bryn Mawr, Philadelphia, USA
Poster Abstracts (of ca. 300 words) with Title, Institution, Address,
Authors and Contact Information should be submitted for review to
eCheminfo [at] douglasconnect.com Poster Abstract submission deadline
is 31 August 2006 although earlier submissions are encouraged.
Posters may be on any topic of relevance to drug discovery and
development but should include new or recent novel research,
application or innovation.
The meeting themes include Structure-based Drug Design, Screening &
Docking, Cheminformatics & Modeling supporting Medicinal Chemistry,
Pharmacophores, Metabolomics, Quantum Biochemistry, Knowledge
Management, Electronic Lab Notebooks, Critical Path Innovation in Drug
Development, Biomarkers, Predictive Toxicology & ADME.
The poster session is planned to take place on the evening of Wednesday
October 18th and will be accompanied by a bbq on campus. If we have
too many posters for viewing that evening, we will also run a second
evening on Monday October 16th.
Open seminars and workshops on Electronic Lab Notebooks and a Knowledge
Cafe on knowledge management in R&D will take place the afternoon &
evening of October 17th. (Open for proposals through 21 July, please
contact barry.hardy [at] douglasconnect.com to discuss program
proposals).
The preliminary main conference and workshop program and schedule for
the meeting is available at:
http://www.echeminfo.com/COMTY_conferences/
best regards
Barry Hardy
eCheminfo Community of Practice
Douglas Connect
Baermeggenweg 14, Zeiningen
CH-4314, Switzerland
Tel: +41 61 851 0170
Barry Hardy wrote:
| Quote: | The eCheminfo Community of Practice InterAction Meeting "Latest
Advances in Drug Discovery Design & Planning Methods" will take place
16-19 October 2006, Bryn Mawr, Philadelphia, USA
Program themes include Structure-based Drug Design, Screening &
Docking, Cheminformatics & Modeling supporting Medicinal Chemistry,
Pharmacophores, Metabolomics, Quantum Biochemistry, Knowledge
Management, Electronic Lab Notebooks, Critical Path Innovation in Drug
Development, Biomarkers, Predictive Toxicology & ADME. In addition to
morning presentations and panel discussions, workshops will run each
afternoon expanding on the discussion of topics and methods and working
through the application of new methods and software to drug discovery &
development problems, with bbq, social activity and poster sessions
running on campus during the evenings.
The preliminary program and schedule is available at:
http://www.echeminfo.com/COMTY_conferences/
Reduced rates apply for early registration through 30 June. Academic
discounts apply.
All registrants are eligible to submit an abstract (ca. 300 words) for
the poster sessions.
Please address any questions related to the conference, exhibition or
workshop program to barry.hardy [at] douglasconnect.com. Registration
enquiries should be directed to eCheminfo [at] douglasconnect.com
best regards
Barry Hardy
eCheminfo Community of Practice
Douglas Connect
Baermeggenweg 14, Zeiningen
CH-4314, Switzerland
Tel: +41 61 851 0170
Confirmed Speakers at the Bryn Mawr meeting include:
Frank Hollinger (Locus Pharmaceuticals), Erin Duffy (Rib-X), Mike
Malams (Wyeth), Debananda Das (NCI), Max Cummings (Johnson & Johnson
PR&D), Lance Westerhoff (QuantumBio), Jose Duca (Schering-Plough),
Osman Guner (Turquoise Consulting), Hege Beard (Schrodinger), Stan
Young (NISS), John Irwin (UCSF), William Douglas Figg (NCI), Daryll
Reid (Simbiosys), Gregory Warren (GlaxoSmithKline), Deepak
Bandyopadhyay (Johnson & Johnson PR&D), Paul Hawkins (OpenEye), Chris
Cooper (BMS), James Arnold (Astra-Zeneca), Phil Edwards (Astra-Zeneca),
Pete Connolly (Johnson & Johnson PR&D), Dimitris Agrafiotis (Johnson &
Johnson PRD), Jim Wikel (Coalesix), Tudor Oprea (Univ. New Mexico),
Alex Tropsha (UNC), Curt Breneman (RPI), Sanji Bhal (ACD/Labs), Michael
Bolger (Simulations Plus), Bob Clark (Tripos), Gilles Klopman
(Multicase), Navita Mallalieu (Roche Pharmaceuticals), Deepak
Bandyopadhyay (Johnson & Johnson PR&D), Zentam Tsuchihashi (BMS), Peter
Henstock (Pfizer), Darius Dziuda (Multivariate bioMarkers Discovery),
Keith Elliston (Genstruct), Michael Liebman (Windber Research
Institute), Jonathan Sheldon (InforSense), Duane Shugars (Concentia
Digital), Jian Wang (Biofortis), Peter Gates (Johnson & Johnson PR&D),
Barry Hardy (Douglas Connect), Dennis Underwood (Praxeon), Jeff
Spitzner (Rescentris), David Mosenkis (Spotfire), Joel Hoffman
(IntraSphere), Delia Wolf (Harvard Medical School), Craig Liddell
(Realtime Science), Joseph Bitran (Enterprizer), Alvin Berger
(Metabolon), Gregory Banik (Bio-RAD), George Harrigan (Monsanto), Rick
Beger (NCTR, FDA), Don Robertson (Pfizer), Teresa Garret (Duke
University), Laszlo Boros (SIDMAP), Bruce Kristal (Cornell University),
Andrew Lane (JG Brown Cancer Center, U. Louisville), Oliver Fiehn (UC
Davis Genome Center), Susan Connor (Glaxo SmithKline) |
|
|
| Back to top |
|
 |
Google
|
|
| Back to top |
|
 |
|
|
The time now is Sat Jan 10, 2009 3:22 am | All times are GMT
|
|
Loans | Guitar Lessons | Ringtones | File Sharing | Air Jordans
|
|
Copyright © 2004-2005 DeniX Solutions SRL
|
|
Other DeniX Solutions sites:
Electronics forum |
Medicine forum |
Unix/Linux blog |
Unix/Linux documentation |
Unix/Linux forums
|
Powered by phpBB © 2001, 2005 phpBB Group
|
|